Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › SC › Anderson › NPI 1417919531

Anmed Health

Anmed Health was paid $75.77M by Medicaid between Jan 2018 and Dec 2024, across 454 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 8.3% of everything it billed.

33Billing provider infoANMED HEALTH
ANDERSON, SC 29621
33aNPI1417919531assigned 04/04/2006
28Total paid$75.77M
24GClaims2,146,189
24DCodes billed454
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Speech-Language Pathologist providers in South Carolina

Rank by total paid#1 of 163
Median peer was paid$157K
This provider vs. median484×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GRIGSBY, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018312,927$9.16M
2019296,161$8.58M
2020254,450$8.07M
2021329,877$12.15M
2022349,778$13.73M
2023329,843$13.99M
2024incomplete273,153$10.10M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
36415 Collection of venous blood by venipuncture 8.3% 79,310 61,672 $6.31M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 6.3% 44,386 41,871 $4.76M
80048 Basic metabolic panel (calcium, ionized) 5.1% 50,678 39,133 $3.86M
J7120 Ringers lactate infusion, up to 1000 cc 4.3% 10,120 8,731 $3.25M
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4.3% 38,689 37,330 $3.24M
80053 Comprehensive metabolic panel 4.2% 55,927 46,127 $3.22M
J7030 Infusion, normal saline solution , 1000 cc 3.7% 14,147 10,459 $2.77M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.4% 46,171 15,506 $2.61M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 3.1% 2,129 2,028 $2.36M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.3% 10,401 9,771 $1.76M
87070 1.9% 31,333 30,193 $1.47M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.8% 16,643 15,701 $1.38M
442 more codes
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.7% 15,340 $1.31M
99283 Emergency room visit (moderate) 1.6% 43,579 $1.21M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.6% 26,393 $1.20M
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.5% 45,979 $1.11M
81001 1.3% 45,881 $990K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1.3% 24,762 $984K
94060 1.3% 2,577 $983K
87486 1.3% 3,984 $963K
99213 Doctor's office visit, returning patient (routine) 1.2% 63,062 $933K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.2% 8,217 $909K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 5,899 $861K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.1% 20,822 $821K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.0% 13,488 $783K
J3490 Unclassified drugs 1.0% 29,801 $779K
82565 1.0% 3,522 $767K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 2,387 $730K
71046 Radiologic examination, chest; 2 views <1% 18,168 $664K
87400 <1% 9,420 $656K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 409 $639K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,831 $637K
82962 <1% 24,439 $574K
93971 <1% 2,065 $509K
77336 <1% 1,471 $480K
71250 <1% 2,124 $443K
81025 <1% 17,050 $408K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 16,084 $407K
76830 Ultrasound, transvaginal <1% 3,605 $404K
93922 <1% 1,248 $395K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 4,670 $372K
99214 Doctor's office visit, returning patient (more involved) <1% 12,018 $371K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 488 $367K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,318 $341K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 18,498 $320K
73610 <1% 4,190 $308K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 39,880 $308K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,599 $295K
70450 Computed tomography, head or brain; without contrast material <1% 9,952 $290K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 6,946 $290K
93296 <1% 1,473 $262K
92526 <1% 3,762 $257K
73630 <1% 4,503 $254K
94010 <1% 1,329 $252K
95886 <1% 1,731 $251K
36600 <1% 1,657 $247K
93970 <1% 1,179 $245K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 544 $242K
74018 <1% 7,301 $241K
73130 <1% 3,399 $236K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,508 $231K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,040 $229K
J7050 Infusion, normal saline solution, 250 cc <1% 2,264 $222K
94664 <1% 1,035 $221K
73110 <1% 2,872 $219K
82803 <1% 2,616 $219K
71045 Radiologic examination, chest; single view <1% 22,849 $218K
87088 <1% 34,097 $218K
84702 <1% 7,947 $212K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,034 $204K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 4,109 $201K
87077 <1% 15,720 $199K
12001 <1% 1,007 $195K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,805 $194K
73030 <1% 3,634 $193K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,078 $178K
99284 Emergency room visit (serious) <1% 30,488 $178K
97116 <1% 13,042 $177K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 10,704 $174K
72100 <1% 4,230 $174K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,128 $172K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,854 $164K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 98,731 $160K
73140 <1% 1,350 $159K
73562 <1% 3,504 $159K
76641 <1% 2,640 $158K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 179 $154K
70551 Magnetic resonance imaging, brain; without contrast material <1% 627 $154K
87653 <1% 3,504 $142K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,727 $138K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 1,129 $137K
93880 <1% 654 $136K
73560 <1% 2,703 $131K
76536 <1% 1,446 $130K
G0378 Hospital observation service, per hour <1% 14,293 $127K
72141 <1% 236 $121K
73090 <1% 1,066 $117K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,603 $113K
72040 <1% 1,756 $111K
84443 Thyroid stimulating hormone (TSH) <1% 23,192 $110K
87210 <1% 2,507 $110K
99285 Emergency room visit (most serious) <1% 16,787 $106K
93299 <1% 423 $102K
97162 <1% 2,892 $100K
94618 <1% 1,851 $98K
87340 <1% 6,263 $98K
73080 <1% 1,250 $98K
12011 <1% 480 $95K
93925 <1% 1,040 $92K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 4,460 $86K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 13,639 $86K
73502 <1% 2,271 $85K
81003 <1% 3,241 $83K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 19,569 $80K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 17,720 $78K
76770 <1% 871 $74K
70486 <1% 624 $72K
73590 <1% 1,467 $72K
80074 <1% 1,579 $65K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,943 $60K
72050 <1% 761 $57K
A9597 Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified <1% 415 $56K
86762 <1% 4,875 $55K
98960 <1% 767 $55K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 6,186 $54K
97161 <1% 2,425 $54K
96361 Intravenous infusion, hydration; each additional hour <1% 19,697 $54K
77062 <1% 257 $52K
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,189 $51K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,843 $51K
97535 Self-care/home management training, each 15 minutes <1% 8,629 $50K
10060 <1% 298 $50K
93458 <1% 464 $48K
88142 <1% 7,756 $48K
97166 <1% 1,729 $48K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 156 $47K
76775 <1% 773 $45K
72125 Computed tomography, cervical spine; without contrast material <1% 2,996 $41K
95816 <1% 252 $40K
87807 <1% 943 $38K
77066 Tomosynthesis, mammo <1% 680 $37K
93017 <1% 2,536 $36K
97597 <1% 818 $34K
85007 <1% 7,033 $33K
86850 <1% 9,463 $33K
J1650 Injection, enoxaparin sodium, 10 mg <1% 7,766 $33K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 702 $32K
93225 <1% 252 $32K
77061 <1% 215 $31K
72072 <1% 498 $31K
77065 Tomosynthesis, mammo <1% 1,055 $30K
85610 <1% 7,653 $30K
73221 <1% 50 $30K
96375 Therapeutic injection; each additional sequential IV push <1% 16,434 $30K
88304 <1% 789 $29K
71101 <1% 462 $28K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,814 $28K
86592 <1% 2,261 $27K
87641 <1% 2,804 $27K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 6,716 $27K
A9270 Non-covered item or service <1% 36,621 $26K
96376 <1% 8,026 $26K
80061 Lipid panel <1% 14,374 $25K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 994 $25K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 5,599 $25K
J2704 Injection, propofol, 10 mg <1% 16,150 $25K
43235 <1% 1,423 $24K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 6,729 $23K
J2270 Injection, morphine sulfate, up to 10 mg <1% 13,703 $22K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 221 $21K
84439 <1% 5,654 $21K
83516 <1% 793 $21K
99215 Doctor's office visit, returning patient (complex) <1% 761 $20K
97533 <1% 4,293 $20K
S9152 Speech therapy, re-evaluation <1% 501 $19K
82728 <1% 4,462 $19K
82607 <1% 3,432 $18K
87505 <1% 282 $18K
84484 <1% 20,779 $17K
87420 <1% 1,258 $17K
84132 <1% 950 $17K
97016 <1% 129 $17K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 19,038 $17K
85027 <1% 13,110 $16K
70496 <1% 222 $14K
29581 <1% 595 $14K
97168 <1% 476 $14K
80076 <1% 9,418 $14K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,531 $14K
93242 <1% 92 $13K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 18,394 $13K
85379 <1% 4,689 $13K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 5,530 $13K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 144 $13K
83735 <1% 12,594 $13K
J1815 Injection, insulin, per 5 units <1% 5,170 $12K
76937 <1% 547 $12K
80069 <1% 1,067 $12K
83880 <1% 6,878 $12K
12002 <1% 82 $11K
99203 Doctor's office visit, new patient (routine) <1% 371 $11K
87040 <1% 5,251 $11K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 4,007 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 7,368 $11K
83036 Hemoglobin; glycosylated (A1C) <1% 9,753 $10K
82570 <1% 4,611 $10K
92610 <1% 183 $10K
36416 <1% 782 $9K
73552 <1% 294 $9K
86780 <1% 5,264 $9K
77334 <1% 183 $9K
74019 <1% 443 $9K
J2060 Injection, lorazepam, 2 mg <1% 2,816 $9K
80047 <1% 86 $8K
97165 <1% 440 $8K
86140 <1% 4,793 $8K
77300 <1% 48 $8K
72170 <1% 235 $8K
83690 <1% 17,063 $8K
73521 <1% 225 $8K
87075 <1% 1,787 $7K
73700 <1% 52 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,836 $7K
86431 <1% 757 $7K
77412 <1% 1,122 $7K
84550 <1% 2,753 $7K
94726 <1% 1,215 $7K
82247 <1% 1,317 $7K
74022 <1% 712 $7K
78815 Positron emission tomography (PET) for limited area imaging <1% 391 $7K
99152 <1% 2,443 $7K
59025 Fetal non-stress test <1% 76 $7K
82043 <1% 1,289 $7K
92607 <1% 94 $7K
82270 <1% 53 $7K
83605 <1% 3,630 $6K
69209 <1% 51 $6K
87205 <1% 3,363 $6K
J3590 Unclassified biologics <1% 2,000 $6K
85652 <1% 4,800 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 299 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 14,951 $6K
83540 <1% 4,134 $6K
88307 <1% 532 $5K
76642 <1% 91 $5K
97164 <1% 187 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,404 $5K
94200 <1% 2,339 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,970 $5K
95012 <1% 518 $5K
83615 <1% 2,734 $5K
87081 <1% 288 $5K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 2,346 $5K
87150 <1% 106 $5K
86308 <1% 269 $5K
76870 <1% 67 $5K
99406 <1% 1,060 $4K
85014 <1% 2,548 $4K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 25 $4K
J1940 Injection, furosemide, up to 20 mg <1% 2,223 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,752 $4K
84100 <1% 3,233 $4K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 205 $4K
51701 <1% 1,286 $4K
82150 <1% 1,216 $4K
95811 <1% 16 $4K
80164 <1% 651 $4K
76801 <1% 71 $4K
73660 <1% 58 $3K
84145 <1% 2,160 $3K
93351 <1% 15 $3K
86003 <1% 133 $3K
92523 <1% 12 $3K
86901 <1% 10,225 $3K
85018 <1% 5,654 $3K
J3480 Injection, potassium chloride, per 2 meq <1% 701 $3K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 149 $3K
82550 <1% 1,824 $2K
78264 <1% 12 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,385 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,070 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 3,684 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 6,153 $2K
83655 <1% 1,542 $2K
86038 <1% 1,264 $2K
93298 <1% 46 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 106 $2K
96523 <1% 15 $2K
96367 <1% 1,766 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,465 $2K
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 1,159 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 16,541 $2K
94729 <1% 2,440 $2K
93926 <1% 13 $2K
87186 <1% 10,822 $2K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 248 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,961 $2K
86703 <1% 102 $2K
95911 <1% 191 $2K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 651 $2K
84146 <1% 300 $2K
94727 <1% 811 $2K
72070 <1% 26 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 11,625 $2K
87493 <1% 45 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,480 $1K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 2,216 $1K
73060 <1% 14 $1K
J2785 Injection, regadenoson, 0.1 mg <1% 1,884 $1K
82784 <1% 737 $1K
70498 <1% 227 $1K
90686 <1% 176 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 380 $1K
83550 <1% 3,584 $1K
82533 <1% 258 $1K
86803 <1% 3,499 $1K
97163 <1% 41 $1K
83970 <1% 792 $1K
97167 <1% 54 $1K
82950 <1% 3,687 $1K
94728 <1% 66 $1K
84153 <1% 639 $987.17
86580 <1% 1,254 $972.92
86900 <1% 9,580 $948.72
76857 <1% 32 $938.27
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 179 $920.12
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 308 $916.72
84156 <1% 2,906 $883.15
87581 <1% 3,887 $844.36
86255 <1% 91 $837.17
85730 <1% 3,698 $828.13
84402 <1% 181 $813.90
29125 <1% 206 $761.02
97755 <1% 26 $716.47
87428 <1% 12 $662.92
90715 <1% 1,741 $634.41
82105 <1% 58 $617.70
87522 Neg quan hep c or qual rna <1% 38 $614.39
83001 <1% 156 $595.59
72082 <1% 12 $576.76
41899 Unlisted procedure, dentoalveolar structures <1% 379 $487.17
82044 <1% 175 $478.86
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 213 $471.37
J3370 Injection, vancomycin hcl, 500 mg <1% 2,038 $462.34
J7999 Compounded drug, not otherwise classified <1% 672 $461.76
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 388 $461.76
96160 <1% 631 $436.59
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 208 $401.93
86706 <1% 14 $370.35
83520 <1% 13 $340.98
82746 <1% 2,037 $339.54
P9021 Red blood cells, each unit <1% 67 $335.62
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,486 $326.86
82951 <1% 478 $299.48
88342 <1% 820 $292.42
C1769 Guide wire <1% 1,638 $253.72
74230 <1% 12 $251.27
84403 <1% 382 $241.14
82947 <1% 106 $235.54
J3105 Injection, terbutaline sulfate, up to 1 mg <1% 13 $222.72
86769 <1% 12 $219.77
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,366 $218.58
91200 <1% 17 $207.04
82140 <1% 221 $168.31
89051 <1% 12 $154.32
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 697 $150.95
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,451 $141.94
82652 <1% 55 $109.00
82010 <1% 829 $78.87
97113 <1% 33 $77.93
82378 <1% 155 $72.86
86664 <1% 14 $69.81
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study <1% 473 $61.25
82977 <1% 16 $59.98
84450 <1% 859 $34.13
85660 <1% 41 $30.55
88173 <1% 29 $24.02
82952 <1% 256 $21.54
87390 <1% 219 $19.34
94667 <1% 29 $17.85
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,806 $16.94
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,773 $13.91
80185 <1% 34 $13.69
J0690 Injection, cefazolin sodium, 500 mg <1% 4,477 $4.70
85045 <1% 185 $4.06
82248 <1% 854 $3.39
J1630 Injection, haloperidol, up to 5 mg <1% 231 $2.63
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 1,673 $0.00
84481 0% 384 $0.00
84460 0% 919 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 1,056 $0.00
92611 0% 12 $0.00
86235 0% 71 $0.00
95028 0% 34 $0.00
86200 0% 13 $0.00
84520 0% 410 $0.00
84630 0% 37 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 43 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 326 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 226 $0.00
86923 0% 824 $0.00
Q9954 Oral magnetic resonance contrast agent, per 100 ml 0% 223 $0.00
J0897 Injection, denosumab, 1 mg 0% 12 $0.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 0% 67 $0.00
82785 0% 63 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 14 $0.00
84425 0% 107 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 123 $0.00
84165 0% 27 $0.00
93356 0% 54 $0.00
86480 0% 12 $0.00
47563 0% 12 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 12 $0.00
J7070 Infusion, d5w, 1000 cc 0% 28 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 40 $0.00
74300 0% 12 $0.00
88112 0% 13 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 38 $0.00
95909 0% 14 $0.00
86665 0% 14 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 57 $0.00
86039 0% 13 $0.00
86231 0% 15 $0.00
86696 0% 12 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 990 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 1,970 $0.00
99153 Mod sedat endo service >5yrs 0% 1,032 $0.00
86225 0% 84 $0.00
J0456 Injection, azithromycin, 500 mg 0% 136 $0.00
83002 0% 14 $0.00
45380 Colonoscopy, flexible; with biopsy, single or multiple 0% 117 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 1,145 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 45 $0.00
36430 0% 497 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 321 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 554 $0.00
29130 0% 14 $0.00
86141 0% 17 $0.00
C9399 Unclassified drugs or biologicals 0% 38 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 1,609 $0.00
80177 0% 28 $0.00
86160 0% 24 $0.00
83021 0% 29 $0.00
86300 0% 16 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 28 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 13 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 0% 25 $0.00
J1335 Injection, ertapenem sodium, 500 mg 0% 20 $0.00
84134 0% 20 $0.00
86364 0% 15 $0.00
90935 Hemodialysis procedure with single evaluation by a physician 0% 70 $0.00
G0379 Direct admission of patient for hospital observation care 0% 14 $0.00
86258 0% 15 $0.00
94668 0% 35 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGRIGSBY, STEPHEN (CFO)
Same official

Other billing entities under GRIGSBY, STEPHEN

Full network →
ProviderLocationPaid
Anmed HealthAnderson, SC$10.28M
Springhill Hospitals, INCMobile, AL$5.30M
Anmed HealthAnderson, SC$4.52M
Anmed HealthAnderson, SC$3.63M
Anmed HealthAnderson, SC$3.02M
Anmed HealthAnderson, SC$2.50M
Anmed HealthAnderson, SC$2.10M
Anmed HealthClemson, SC$1.58M
Anmed HealthAnderson, SC$1.47M
Anmed HealthWilliamston, SC$1.27M
Anmed HealthAnderson, SC$1.24M
Anmed HealthAnderson, SC$1.15M
Anmed HealthAnderson, SC$889K
Anmed HealthClemson, SC$867K
Anmed HealthPiedmont, SC$864K
Anmed HealthIva, SC$791K
Anmed HealthAnderson, SC$764K
Anmed HealthHonea Path, SC$713K
Anmed HealthAnderson, SC$513K
Anmed HealthAnderson, SC$512K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.